Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09775 | 31614673 | Cells | Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells. | 2019 | Details |
| A09776 | 31614650 | J Clin Med | Polyphenol-Rich Extracts from Toona sinensis Bark and Fruit Ameliorate Free Fatty Acid-Induced Lipogenesis through AMPK and LC3 Pathways. | 2019 | Details |
| A09777 | 31614639 | Biomolecules | Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats. | 2019 | Details |
| A09778 | 31614590 | Int J Mol Sci | Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells. | 2019 | Details |
| A09779 | 31614491 | Int J Mol Sci | Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. | 2019 | Details |
| A09780 | 31613826 | Menopause | Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women. | 2020 | Details |
| A09782 | 31612634 | Liver Int | Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes. | 2019 | Details |
| A09783 | 31611038 | Lancet HIV | Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. | 2019 | Details |
| A09785 | 31611031 | Clin Res Hepatol Gastroenterol | Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid. | 2019 | Details |
| A09786 | 31610584 | Z Gastroenterol | A 2-step fast-track elastometry service for advanced workup of nonalcoholic fatty liver disease (NAFLD) patients - single-center real-world experience of outpatient clinical practice. | 2019 | Details |
| A09787 | 31610178 | Am J Pathol | Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice. | 2019 | Details |
| A09788 | 31610126 | J Agric Food Chem | Reduction of Hepatic Lipogenesis by Loliolide and Pinoresinol from Lysimachia vulgaris via Degrading Liver X Receptors. | 2019 | Details |
| A09789 | 31610081 | Liver Transpl | Nonalcoholic Steatohepatitis After Liver Transplantation. | 2019 | Details |
| A09792 | 31609745 | Clin Transl Gastroenterol | Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard. | 2019 | Details |
| A09793 | 31608477 | J Food Biochem | Zingiber officinale extract and omega-3 fatty acids ameliorate endoplasmic reticulum stress in a nonalcoholic fatty liver rat model. | 2019 | Details |
| A09794 | 31608220 | J Clin Transl Hepatol | Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing? | 2019 | Details |
| A09795 | 31607647 | Ann Hepatol | Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies. | 2019 | Details |
| A09796 | 31607566 | Dig Liver Dis | L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet. | 2019 | Details |
| A09798 | 31606352 | Ann Hepatol | Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? | 2019 | Details |
| A09799 | 31605031 | Nat Rev Gastroenterol Hepatol | Adaptive immunity: an emerging player in the progression of NAFLD. | 2019 | Details |
| A09800 | 31604965 | Sci Rep | Depletion of CD40 on CD11c+ cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH. | 2019 | Details |
| A09801 | 31604805 | J Lipid Res | Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis. | 2019 | Details |
| A09802 | 31604692 | Diabetes Care | Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes. | 2019 | Details |
| A09803 | 31604171 | Atherosclerosis | Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors. | 2019 | Details |
| A09804 | 31604107 | Life Sci | Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. | 2019 | Details |
| A09805 | 31604029 | Am J Physiol Gastrointest Liver Physiol | Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model. | 2019 | Details |
| A09807 | 31602953 | Zhongguo Zhong Yao Za Zhi | [Mechanism of Calculus Bovis Sativus in inhibiting hepatocyte lipid deposition based on serum pharmacology]. | 2019 | Details |
| A09808 | 31602526 | J Gastroenterol | Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients. | 2019 | Details |
| A09809 | 31602167 | World J Gastroenterol | Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. | 2019 | Details |
| A09810 | 31601335 | Wei Sheng Yan Jiu | [Case-control study of the relationship between dietary fatty acids intake and non-alcoholic fatty liver disease in Nanping City, 2015-2017]. | 2019 | Details |
| A09811 | 31601229 | Trials | Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol. | 2019 | Details |
| A09812 | 31601203 | BMC Endocr Disord | Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. | 2019 | Details |
| A09813 | 31600834 | Hepatology | qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A09814 | 31600750 | Digestion | Rodent Models of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09815 | 31599882 | Rev Invest Clin | INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, NON-ALCOHOLIC FATTY LIVER DISEASE, AND ITS RELATIONSHIP WITH FRUCTOSE CONSUMPTION IN CHILDREN WITH OBESITY. | 2019 | Details |
| A09816 | 31599742 | Am J Gastroenterol | The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease. | 2019 | Details |
| A09817 | 31599445 | Eur Rev Med Pharmacol Sci | Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation. | 2019 | Details |
| A09818 | 31599067 | Mol Nutr Food Res | Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy-Confirmed Mouse Model of Advanced Non-Alcoholic Steatohepatitis and Fibrosis. | 2019 | Details |
| A09819 | 31598919 | Dig Dis Sci | A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA. | 2019 | Details |
| A09820 | 31598559 | Clin Exp Hepatol | Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study. | 2019 | Details |
| A09821 | 31598192 | World J Hepatol | Cirrhotic patients and older people. | 2019 | Details |
| A09822 | 31598135 | Therap Adv Gastroenterol | Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2019 | Details |
| A09823 | 31597937 | Sci Rep | Author Correction: Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. | 2019 | Details |
| A09824 | 31597900 | Nihon Yakurigaku Zasshi | [Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis]. | 2019 | Details |
| A09825 | 31597607 | Trends Endocrinol Metab | Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09827 | 31597406 | Cells | A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09828 | 31597206 | J Gastroenterol Hepatol | The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis. | 2019 | Details |
| A09829 | 31597010 | Liver Transpl | Increased Frequency of Heterozygous Alpha-1-Antitrypsin Deficiency in Liver Explants From Nonalcoholic Steatohepatitis Patients. | 2019 | Details |
| A09830 | 31595673 | EMBO Mol Med | Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis. | 2019 | Details |
| A09832 | 31595464 | J Gen Intern Med | Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study. | 2019 | Details |
| A09833 | 31595260 | Porto Biomed J | Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. | 2018 | Details |
| A09834 | 31595236 | Porto Biomed J | Dietary cholesterol does not break your heart but kills your liver. | 2019 | Details |
| A09835 | 31595205 | Aging Dis | Pyroptosis in Liver Disease: New Insights into Disease Mechanisms. | 2019 | Details |
| A09836 | 31594780 | BMJ | Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. | 2019 | Details |
| A09837 | 31594758 | Ann Hepatol | Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations. | 2019 | Details |
| A09838 | 31594173 | Zhonghua Nei Ke Za Zhi | [Characteristics and clinical significance of body composition in gout patients]. | 2019 | Details |
| A09839 | 31594102 | Zhonghua Gan Zang Bing Za Zhi | [Research advances in the relationship between nonalcoholic fatty fiver disease and sarcopenia]. | 2019 | Details |
| A09840 | 31594095 | Zhonghua Gan Zang Bing Za Zhi | [Study on the correlation between small intestinal dendritic cells and non-alcoholic fatty liver disease in mice]. | 2019 | Details |
| A09841 | 31594008 | Ultraschall Med | Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements. | 2019 | Details |
| A09842 | 31593687 | Eur J Pharmacol | Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. | 2019 | Details |
| A09844 | 31593012 | Pancreas | The Prevalence of Nonalcoholic Fatty Pancreas by Endoscopic Ultrasonography. | 2019 | Details |
| A09845 | 31592493 | Hepatol Commun | Impact of Hepatic Steatosis on Resting Metabolic Rate and Metabolic Adaptation in Response to Intentional Weight Loss. | 2019 | Details |
| A09846 | 31592492 | Hepatol Commun | Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016. | 2019 | Details |
| A09847 | 31592448 | Endocrinol Diabetes Metab | Hepatic steatosis in patients with acromegaly. | 2019 | Details |
| A09848 | 31592078 | Hepatol Commun | Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics. | 2019 | Details |
| A09849 | 31592044 | Hepatol Commun | Impact of Implementing a "FIB-4 First" Strategy on a Pathway for Patients With NAFLD Referred From Primary Care. | 2019 | Details |
| A09850 | 31592021 | Hepatol Commun | Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation-Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl-Coenzyme A Desaturase As an Enhancer RNA. | 2019 | Details |
| A09853 | 31591383 | Cell Death Dis | Progranulin attenuates liver fibrosis by downregulating the inflammatory response. | 2019 | Details |
| A09854 | 31591263 | Mol Cell Proteomics | Absolute Quantification of Apolipoproteins Following Treatment with Omega-3 Carboxylic Acids and Fenofibrate Using a High Precision Stable Isotope-labeled Recombinant Protein Fragments Based SRM Assay. | 2019 | Details |
| A09855 | 31590127 | Biomed Pharmacother | Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. | 2019 | Details |
| A09856 | 31590120 | Curr Opin Pharmacol | New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases. | 2019 | Details |
| A09857 | 31589891 | J Hepatol | Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis. | 2019 | Details |
| A09858 | 31589177 | Curr Opin Clin Nutr Metab Care | Vitamin D and nonalcoholic fatty liver disease. | 2019 | Details |
| A09859 | 31589122 | Curr Drug Targets | Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A09860 | 31588816 | Arch Physiol Biochem | The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A09865 | 31584681 | JAMA Netw Open | Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09866 | 31584360 | Curr Med Chem | Stem Cell Transplant for Advanced Stage Liver Disorders: Current Scenario and Future Prospects. | 2020 | Details |
| A09867 | 31583739 | Aliment Pharmacol Ther | Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. | 2019 | Details |
| A09868 | 31583002 | Iran J Pathol | Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals. | 2019 | Details |
| A09869 | 31582326 | Dig Liver Dis | Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. | 2019 | Details |
| A09870 | 31582009 | Med Clin North Am | Genetic Causes of Liver Disease: When to Suspect a Genetic Etiology, Initial Lab Testing, and the Basics of Management. | 2019 | Details |
| A09871 | 31581841 | Chronobiol Int | Working hours and nonalcoholic fatty liver disease according to sleep duration. | 2019 | Details |
| A09872 | 31581241 | PLoS Comput Biol | A computational model of postprandial adipose tissue lipid metabolism derived using human arteriovenous stable isotope tracer data. | 2019 | Details |
| A09873 | 31581129 | Endocr Connect | Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation? | 2019 | Details |
| A09874 | 31580887 | Regul Toxicol Pharmacol | Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. | 2019 | Details |
| A09875 | 31579588 | PeerJ | FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice. | 2019 | Details |
| A09876 | 31578240 | Sci Transl Med | Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates. | 2019 | Details |
| A09877 | 30687796 | Wellcome Open Res | Metabolic profiling of adolescent non-alcoholic fatty liver disease. | 2019 | Details |
| A09878 | 31577913 | FASEB J | Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities. | 2019 | Details |
| A09879 | 31577570 | Am J Gastroenterol | Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study. | 2019 | Details |
| A09880 | 31577134 | Anal Chem | Comparative Glycomic Analysis of Sialyl Linkage Isomers by Sialic Acid Linkage-Specific Alkylamidation in Combination with Stable Isotope Labeling of α2,3-Linked Sialic Acid Residues. | 2019 | Details |
| A09881 | 31576092 | World J Gastroenterol | Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. | 2019 | Details |
| A09882 | 31575546 | Cancer Res | HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. | 2019 | Details |
| A09883 | 31575467 | Ann Hepatol | Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis. | 2019 | Details |
| A09884 | 31575419 | Am J Surg | Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis. | 2019 | Details |
| A09885 | 31574842 | Medicine (Baltimore) | Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery. | 2019 | Details |
| A09886 | 31574533 | Carcinogenesis | Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation. | 2020 | Details |
| A09887 | 31574313 | Clin Gastroenterol Hepatol | Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09888 | 31574193 | Mol Nutr Food Res | Green Tea Extract Treatment in Obese Mice with Nonalcoholic Steatohepatitis Restores the Hepatic Metabolome in Association with Limiting Endotoxemia-TLR4-NFκB-Mediated Inflammation. | 2019 | Details |
| A09889 | 31574071 | Gastroenterol Nurs | Nonalcoholic Fatty Liver Disease: A Silent Epidemic. | 2020 | Details |